Zero Point Five Therapeutics, Inc.

New Filing
CIK: 0001985295·Biotechnology·DELAWARE·Filed: Jul 12, 2023
Total Offering

$10,140,859

Amount Sold

$7,220,517

Investors

15

First Sale

Jun 27, 2023

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2018
Non-Accredited Investors
No

Related Persons

NameRole
Joseph Amprey III
Related Person
Ben Auspitz
Related Person
Jodi Jahic
Related Person

Company

Zero Point Five Therapeutics, Inc.

915 S. EATON STREET

BALTIMORE, MD, 21224

301-327-0118

SEC Filing

0001985295-23-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Zero Point Five Therapeutics, Inc. Form D Filing — $10,140,859 | FilingFlow